Breast Cancer Monoclonal Antibodies Market Share, Size, Trends and Forecasts to 2020

Technavio Announces the Publication of its Research Report Global Breast Cancer Monoclonal Antibodies (mAbs) Market 2016-2020

Technavio recognizes the following companies as the key players in the global breast cancer monoclonal antibodies (mAbs) market: Roche, Amgen, and Mylan.

Other Prominent Vendors in the market are: Actavis, Array BioPharma, AstraZeneca, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Celltrion, Chugai Pharmaceutical, Daiichi Sankyo, DARA Biosciences, Eddingpharm, Eisai, Galena Biopharma, GlaxoSmithKline, Halozyme Therapeutics, Hospira, ImmunoGen, Immunomedics, MacroGenics, Merck, Novartis, Oncothyreon, Pfizer, ProStrakan, Puma Biotechnology, Seattle Genetics, Sun Pharmaceutical Industriesf, Synta Pharmaceuticals, and Teva Pharmaceuticals.

Browse full report with TOC@ https://marketreportscenter.com/reports/388339/global-breast-cancer-monoclonal-antibodies-market-2016-2020

Commenting on the report, an analyst from Technavios team said: Huge funds are required for a company to enter the global breast cancer mAbs market and invest in the R&D and manufacturing processes related to the same. Vendors have identified mAb products as a significant long-term growth opportunity. The pharmaceutical industry is a research-intensive industry backed by developments in technology. The vendors in this market are allocating huge R&D budgets to enable the introduction of a broad portfolio of mAbs. This would help increase the market penetration of the vendors in the global market to a great extent. Thus, the huge investment in the R&D of mAbs is another trend witnessed by the global breast cancer mAbs market, influencing market growth.”

According to the report, exposure to risk factors will be a key driver for market growth. Exposure to risk factors for breast cancer and the decrease in practices that reduce this risk are expected to increase the incidence of breast cancer. The disease is associated with modifiable...